DOYLESTOWN, Pa., March 30, 2020 — Diverse Biotech, Inc. www.diversebiotech.com has announced it has signed an initial partnership agreement with The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center to study its potential new therapeutic candidates in glioblastoma. The research will be performed in animal models of the disease to evaluate the...Read More

In 2014, the entire genome of Cannabis stavia L. was sequenced. This news received national attention with eye-catching headlines such as: “Marijuana Genome Sequenced for Health, Not Highs”. Researchers and oncologists took note, not due to the attention-grabbing headlines, but because their focus was to pair the decoded cannabis genome research with sequencing of the […]Read More

In the simplest of terms, DNA, or deoxyribonucleic acid, is the genetic code that determines all the characteristics of a living thing. This double, long chain of molecules called nucleotides tell each cell what proteins to make, giving them the genetic instruction guide for life and its processes. Each cell’s development, reproduction and death are […]Read More

It is estimated that more than 240,000 cases of brain and nervous system tumors are diagnosed each year around the world. The most common and most lethal of these cancerous tumors are glioblastoma (GBM). What is Glioblastoma? Glioblastoma is a type of glioma, which is a brain tumor that begins in the star-shaped glial cells […]Read More

According to the American Cancer Society, scientists have recently reported that THC and other cannabinoids such as CBD slow growth and/or cause death in certain types of cancer cells growing in lab dishes. This is not only fascinating, but encouraging news for not only researchers, but those who are diagnosed with cancer, or have a […]Read More

Glioblastoma originates in the brain and typically does not spread to other parts of the body. It is a particularly difficult cancer to treat because tumors often overlap with healthy brain tissue making full surgical removal usually impossible. Treatments such as chemotherapy and radiation may slow the disease’s progression, but there is currently no cure. […]Read More

President Trump is expected to sign the 2018 Farm Bill, a massive, five-year piece of legislation that outlines regulations on everything from food stamps to environmental land use. This particular Farm Bill has one piece of legislature that previous versions have not included – it is legalizing industrial hemp, including the plants used to produce […]Read More

The term “cannabinoids” originally described bioactive constituents of the plant Cannabis sativa, a plant that can grow wild in mild, tropical climates around the world. For centuries, the cannabis ingredients were used traditionally for their medicinal purpose but also for their recreational properties; however, only since the 1940s have cannabinoids been purified from cannabis plants. […]Read More

The industrial hemp market is heating up, with manufacturers, researchers, physicians, and patients, awaiting the passage of the 2018 Farm Bill and the expected removal of hemp from the Controlled Substances Act. Businesses are moving to position themselves as top suppliers of hemp-based CBD products and investors are eagerly helping fund these endeavors. As the […]Read More

The hemp industry has been waiting months for Congress to take action on a new Farm Bill, one that could make legal barriers for hemp production disappear. With the Thanksgiving holiday behind us, Congress has returned to session. Lawmakers in the Nation’s capital are putting more focus on the new Farm Bill, which not only […]Read More